한국인 성인발생 및 후기발생 근긴장디스트로피제 1형 환자의 임상 특성
Clinical Characteristics of the Korean Patients with Adult Onset and Late Onset Myotonic Dystrophy Type 1
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: To investigate the clinical characteristics and complications of Korean patients with myotonic dystrophy type 1 (DM1). Method: The medical records of 65 DM1 patients were reviewed retrospectively. We assessed the relationship between the age of onset, muscular impairment rating scale (MIRS) and complications of the DM1 with the number of cytosine-thymine-guanine (CTG) repeats. Results: The mean age of onset was 30.5 ± 10.3 years and the mean disease duration until diagnosis was 6.1 ± 6.0 years. The age of onset was inversely correlated to the number of CTG repeats (P = 0.034). For the systemic complications, 20 of 55 patients (36.4%) had arrhythmia, 18 of 49 patients (36.7%) needed ventilator support, 4 of 52 (7.7%) had diabetes mellitus and 19 of 35 (54.3%) had cataracts. The difference between the number of CTG repeats of patients with these complications and that of patients without complications was not significant. Conclusion: Regular follow-ups of electrocardiogram, pulmonary function test, blood sugar test and ocular examination is recommended for the patients with DM1.
Abstract
Objective: To investigate the clinical characteristics and complications of Korean patients with myotonic dystrophy type 1 (DM1). Method: The medical records of 65 DM1 patients were reviewed retrospectively. We assessed the relationship between the age of onset, muscular impairment rating scale (MIRS) and complications of the DM1 with the number of cytosine-thymine-guanine (CTG) repeats. Results: The mean age of onset was 30.5 ± 10.3 years and the mean disease duration until diagnosis was 6.1 ± 6.0 years. The age of onset was inversely correlated to the number of CTG repeats (P = 0.034). For the systemic complications, 20 of 55 patients (36.4%) had arrhythmia, 18 of 49 patients (36.7%) needed ventilator support, 4 of 52 (7.7%) had diabetes mellitus and 19 of 35 (54.3%) had cataracts. The difference between the number of CTG repeats of patients with these complications and that of patients without complications was not significant. Conclusion: Regular follow-ups of electrocardiogram, pulmonary function test, blood sugar test and ocular examination is recommended for the patients with DM1.
참고문헌 (16)
- Turner C, "The myotonic dystrophies:diagnosis and management", J Neurol Neurosurg Psychiatry, 81, pp.358~367 (2010)
- Meola G, "Clinical and genetic heterogeneity in myotonic dystrophies", Muscle Nerve, 23, pp.1789~1799 (2000)
- Winblad S, "Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates", Behav Brain Funct, 6, pp.25~ (2010)
- Shieh K, "Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy", Muscle Nerve, 41, pp.197~201 (2010)
- Mathieu J, "A 10-year study of mortality in a cohort of patients with myotonic dystrophy", Neurology, 52, pp.1658~1662 (1999)
- de Die-Smulders CE, "Age and causes of death in adult-onset myotonic dystrophy", Brain, 121(Pt 8), pp.1557~1563 (1998)
- Lindqvist P, "Ventricular dysfunction in type 1 myotonic dystrophy: electrical, mechanical, or both?", Int J Cardiol, 143, pp.378~384 (2010)
- Choi BO, "Clinical Significance of CTG Repeat Expansion in Korean Myotonic Dystrophy Patients", J Kor Neurol Ass, 17, pp.548~553 (1999)
- Mathieu J, "Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy", Neurology, 56, pp.336~340 (2001)
- Groh WJ, "Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1", N Engl J Med 2008, 358, pp.2688~2697 (2008)
- Park CI, "Rehabilitation medicine", pp.644~ (2012), Hanmi medical publishing co.
- Meola G, "Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms", Biochim Biophys Acta (2014)
- Monteiro R, "Genetics correlates with lung function and nocturnal ventilation in myotonic dystrophy", Sleep Breath, 17, pp.1087~1092 (2013)
- Ristow M, "Neurodegenerative disorders associated with diabetes mellitus", J Mol Med (Berl), 82, pp.510~529 (2004)
- Meola G, "Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies", Acta Myol, 32, pp.154~165 (2013)